| Pervasis Receives Orphan Drug Designation in Europe for Vascugel® to Prevent ... - PR Newswire (press release) |
|
|
PR Newswire (press release) Vascugel is a novel endothelial cell-based therapy that aims to regulate the body's healing response following surgical interventions to create vascular access which are necessary for ESRD patients undergoing hemodialysis. By promoting and enhancing |